ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome

This study is ongoing, but not recruiting participants.

Sponsored by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00001254
  Purpose

This protocol concerns the approach to the localization, diagnosis of MEN1 and management of the tumor and the tissue samples in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor, investigations for MEN1 the subsequent management of the tumor and tissue samples for research.


Condition
Gastrinoma
Zollinger Ellison Syndrome

MedlinePlus related topics:   Cancer   

U.S. FDA Resources

Study Type:   Observational
Official Title:   Evaluation of the Gastrinoma in Patients With Zollinger-Ellison Syndrome

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment:   999
Study Start Date:   May 1990

Detailed Description:

This protocol concerns the localization and management of the tumor in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor and the subsequent management of the tumor.

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria
  • INCLUSION CRITERIA:

New patients will be evaluated initially as described in the protocol entitled, "Diagnostic evaluation of patients with suspected abnormalities of gastric secretion" (89-DK-0005).

Only those patients that are being treated under the protocol entitled, "Medical Therapy of Zollinger-Ellison Syndrome" (protocol # 89-DK-0015) will be entered into this tumor localization and management protocol.

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00001254

Locations
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike    
      Bethesda, Maryland, United States, 20892

Sponsors and Collaborators
  More Information

NIH Clinical Center Detailed Web Page  This link exits the ClinicalTrials.gov site
 

Publications:

Study ID Numbers:   900137, 90-DK-0137
First Received:   November 3, 1999
Last Updated:   July 18, 2008
ClinicalTrials.gov Identifier:   NCT00001254
Health Authority:   United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Islet Cell Tumors  

Study placed in the following topic categories:
Digestive System Neoplasms
Gastrointestinal Diseases
Ulcer
Pancreatic Neoplasms
Carcinoma, Islet Cell
Endocrine System Diseases
Intestinal Diseases
Carcinoma
Stomach Diseases
Paraneoplastic Syndromes
Gastrinoma
Digestive System Diseases
Zollinger-Ellison Syndrome
Zollinger-Ellison syndrome
Gastrointestinal Neoplasms
Pancreatic Diseases
Endocrinopathy
Adenocarcinoma
Pancreatic islet cell tumors
Peptic Ulcer
Neoplasms, Glandular and Epithelial
Endocrine Gland Neoplasms

Additional relevant MeSH terms:
Neoplasms
Pathologic Processes
Disease
Neoplasms by Site
Neoplasms by Histologic Type
Syndrome
Paraneoplastic Endocrine Syndromes

ClinicalTrials.gov processed this record on September 05, 2008




Links to all studies - primarily for crawlers